Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Sales | 102,009 | 69,100 | 43,471 | 31,870 | 11,080 |
| Cost of Goods | 34,946 | 23,356 | 12,491 | 8,160 | 5,030 |
| Gross Profit | 67,063 | 45,744 | 30,980 | 23,710 | 6,040 |
| Operating Expenses | 21,595 | 13,678 | 11,323 | 5,210 | 2,860 |
| Operating Income | 46,414 | 32,422 | 20,148 | 18,500 | 3,190 |
| Interest Expense | 229 | 28 | 158 | 380 | 170 |
| Other Income | 7,916 | 5,288 | 1,979 | 300 | 110 |
| Pre-tax Income | 54,101 | 37,682 | 21,969 | 18,420 | 3,130 |
| Income Tax | 19,707 | 14,089 | 8,195 | 6,970 | 940 |
| Net Income Continuous | 34,394 | 23,593 | 13,774 | 11,445 | 2,189 |
| Net Income | $34,394 | $23,593 | $13,774 | $11,440 | $2,180 |
| EPS Basic Total Ops | 1.04 | 0.78 | 0.51 | 0.54 | 0.10 |
| EPS Basic Continuous Ops | 1.04 | 0.78 | 0.51 | 0.54 | 0.10 |
| EPS Diluted Total Ops | 1.01 | 0.74 | 0.46 | 0.48 | 0.09 |
| EPS Diluted Continuous Ops | 1.01 | 0.74 | 0.46 | 0.47 | 0.09 |
| EBITDA(a) | $51,618 | $34,835 | $21,973 | $19,550 | $3,870 |